Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-25-016189
Filing Date
2025-02-21
Accepted
2025-02-21 18:16:47
Documents
1
Period of Report
2025-02-20

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 3735
  Complete submission text file 0001213900-25-016189.txt   5264
Mailing Address 1600 BROADWAY SUITE 1360 DENVER CO 80202
Business Address
Smith Ryan Lewis (Reporting) CIK: 0001619129 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38105 | Film No.: 25653574

Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Issuer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)